GPI anchor biosynthesis, GPI-anchor transamidase subunit 8 (GPI8) GPI8
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 6, no: 4 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0008303 | caspase complex | 5 | 11 |
| GO:0032991 | protein-containing complex | 1 | 11 |
| GO:0042765 | GPI-anchor transamidase complex | 3 | 11 |
| GO:0098796 | membrane protein complex | 2 | 11 |
| GO:0140534 | endoplasmic reticulum protein-containing complex | 2 | 11 |
| GO:1902494 | catalytic complex | 2 | 11 |
| GO:1905368 | peptidase complex | 3 | 11 |
| GO:1905369 | endopeptidase complex | 4 | 11 |
| GO:0005635 | nuclear envelope | 4 | 1 |
| GO:0005783 | endoplasmic reticulum | 5 | 1 |
| GO:0031967 | organelle envelope | 3 | 1 |
| GO:0031975 | envelope | 2 | 1 |
| GO:0043226 | organelle | 2 | 1 |
| GO:0043227 | membrane-bounded organelle | 3 | 1 |
| GO:0043229 | intracellular organelle | 3 | 1 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HXR1
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006508 | proteolysis | 4 | 11 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
| GO:0008152 | metabolic process | 1 | 11 |
| GO:0016255 | attachment of GPI anchor to protein | 5 | 11 |
| GO:0019538 | protein metabolic process | 3 | 11 |
| GO:0036211 | protein modification process | 4 | 11 |
| GO:0043170 | macromolecule metabolic process | 3 | 11 |
| GO:0043412 | macromolecule modification | 4 | 11 |
| GO:0044238 | primary metabolic process | 2 | 11 |
| GO:0071704 | organic substance metabolic process | 2 | 11 |
| GO:1901564 | organonitrogen compound metabolic process | 3 | 11 |
| GO:0008104 | protein localization | 4 | 1 |
| GO:0009987 | cellular process | 1 | 1 |
| GO:0033036 | macromolecule localization | 2 | 1 |
| GO:0034394 | protein localization to cell surface | 5 | 1 |
| GO:0051179 | localization | 1 | 1 |
| GO:0051641 | cellular localization | 2 | 1 |
| GO:0070727 | cellular macromolecule localization | 3 | 1 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 11 |
| GO:0003923 | GPI-anchor transamidase activity | 6 | 11 |
| GO:0004175 | endopeptidase activity | 4 | 11 |
| GO:0004197 | cysteine-type endopeptidase activity | 5 | 11 |
| GO:0008233 | peptidase activity | 3 | 11 |
| GO:0008234 | cysteine-type peptidase activity | 4 | 11 |
| GO:0016787 | hydrolase activity | 2 | 11 |
| GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 146 | 148 | PF00675 | 0.470 |
| CLV_NRD_NRD_1 | 164 | 166 | PF00675 | 0.398 |
| CLV_NRD_NRD_1 | 211 | 213 | PF00675 | 0.460 |
| CLV_NRD_NRD_1 | 285 | 287 | PF00675 | 0.625 |
| CLV_PCSK_KEX2_1 | 146 | 148 | PF00082 | 0.470 |
| CLV_PCSK_KEX2_1 | 164 | 166 | PF00082 | 0.398 |
| CLV_PCSK_KEX2_1 | 211 | 213 | PF00082 | 0.473 |
| CLV_PCSK_KEX2_1 | 285 | 287 | PF00082 | 0.602 |
| CLV_PCSK_SKI1_1 | 146 | 150 | PF00082 | 0.459 |
| CLV_PCSK_SKI1_1 | 164 | 168 | PF00082 | 0.465 |
| CLV_PCSK_SKI1_1 | 184 | 188 | PF00082 | 0.326 |
| CLV_PCSK_SKI1_1 | 215 | 219 | PF00082 | 0.456 |
| CLV_PCSK_SKI1_1 | 63 | 67 | PF00082 | 0.473 |
| DEG_APCC_DBOX_1 | 145 | 153 | PF00400 | 0.273 |
| DOC_CYCLIN_RxL_1 | 161 | 170 | PF00134 | 0.339 |
| DOC_MAPK_gen_1 | 211 | 219 | PF00069 | 0.259 |
| DOC_MAPK_HePTP_8 | 339 | 351 | PF00069 | 0.305 |
| DOC_MAPK_MEF2A_6 | 171 | 178 | PF00069 | 0.279 |
| DOC_MAPK_MEF2A_6 | 342 | 351 | PF00069 | 0.378 |
| DOC_PP1_RVXF_1 | 213 | 219 | PF00149 | 0.274 |
| DOC_PP4_FxxP_1 | 112 | 115 | PF00568 | 0.329 |
| DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.466 |
| DOC_USP7_MATH_2 | 108 | 114 | PF00917 | 0.307 |
| DOC_USP7_UBL2_3 | 184 | 188 | PF12436 | 0.339 |
| DOC_WW_Pin1_4 | 157 | 162 | PF00397 | 0.273 |
| LIG_14-3-3_CanoR_1 | 146 | 152 | PF00244 | 0.332 |
| LIG_14-3-3_CanoR_1 | 164 | 174 | PF00244 | 0.179 |
| LIG_14-3-3_CanoR_1 | 6 | 16 | PF00244 | 0.507 |
| LIG_14-3-3_CanoR_1 | 69 | 77 | PF00244 | 0.258 |
| LIG_BIR_III_4 | 120 | 124 | PF00653 | 0.237 |
| LIG_BRCT_BRCA1_1 | 95 | 99 | PF00533 | 0.339 |
| LIG_deltaCOP1_diTrp_1 | 332 | 338 | PF00928 | 0.344 |
| LIG_FHA_1 | 161 | 167 | PF00498 | 0.334 |
| LIG_FHA_1 | 190 | 196 | PF00498 | 0.329 |
| LIG_FHA_1 | 258 | 264 | PF00498 | 0.307 |
| LIG_FHA_1 | 282 | 288 | PF00498 | 0.421 |
| LIG_FHA_1 | 8 | 14 | PF00498 | 0.445 |
| LIG_LIR_Apic_2 | 110 | 115 | PF02991 | 0.297 |
| LIG_LIR_Gen_1 | 26 | 37 | PF02991 | 0.399 |
| LIG_LIR_Gen_1 | 52 | 59 | PF02991 | 0.258 |
| LIG_LIR_Gen_1 | 76 | 86 | PF02991 | 0.339 |
| LIG_LIR_LC3C_4 | 10 | 15 | PF02991 | 0.340 |
| LIG_LIR_Nem_3 | 185 | 189 | PF02991 | 0.267 |
| LIG_LIR_Nem_3 | 26 | 32 | PF02991 | 0.395 |
| LIG_LIR_Nem_3 | 269 | 274 | PF02991 | 0.300 |
| LIG_LIR_Nem_3 | 298 | 302 | PF02991 | 0.281 |
| LIG_LIR_Nem_3 | 52 | 58 | PF02991 | 0.250 |
| LIG_LIR_Nem_3 | 76 | 81 | PF02991 | 0.302 |
| LIG_REV1ctd_RIR_1 | 184 | 192 | PF16727 | 0.209 |
| LIG_SH2_CRK | 213 | 217 | PF00017 | 0.273 |
| LIG_SH2_CRK | 271 | 275 | PF00017 | 0.290 |
| LIG_SH2_CRK | 29 | 33 | PF00017 | 0.400 |
| LIG_SH2_CRK | 78 | 82 | PF00017 | 0.339 |
| LIG_SH2_STAP1 | 250 | 254 | PF00017 | 0.289 |
| LIG_SH2_STAP1 | 29 | 33 | PF00017 | 0.459 |
| LIG_SH2_STAT3 | 250 | 253 | PF00017 | 0.329 |
| LIG_SH2_STAT3 | 254 | 257 | PF00017 | 0.329 |
| LIG_SH2_STAT5 | 177 | 180 | PF00017 | 0.291 |
| LIG_SH2_STAT5 | 64 | 67 | PF00017 | 0.259 |
| LIG_SH3_3 | 229 | 235 | PF00018 | 0.362 |
| LIG_SH3_3 | 321 | 327 | PF00018 | 0.335 |
| LIG_SUMO_SIM_anti_2 | 10 | 17 | PF11976 | 0.340 |
| LIG_SUMO_SIM_anti_2 | 290 | 296 | PF11976 | 0.373 |
| LIG_SUMO_SIM_par_1 | 14 | 20 | PF11976 | 0.313 |
| LIG_WRC_WIRS_1 | 262 | 267 | PF05994 | 0.292 |
| MOD_CDK_SPxxK_3 | 157 | 164 | PF00069 | 0.273 |
| MOD_CK1_1 | 198 | 204 | PF00069 | 0.362 |
| MOD_CK1_1 | 23 | 29 | PF00069 | 0.633 |
| MOD_CK2_1 | 240 | 246 | PF00069 | 0.312 |
| MOD_GlcNHglycan | 132 | 135 | PF01048 | 0.514 |
| MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.705 |
| MOD_GSK3_1 | 165 | 172 | PF00069 | 0.265 |
| MOD_GSK3_1 | 189 | 196 | PF00069 | 0.273 |
| MOD_GSK3_1 | 19 | 26 | PF00069 | 0.398 |
| MOD_GSK3_1 | 240 | 247 | PF00069 | 0.313 |
| MOD_GSK3_1 | 257 | 264 | PF00069 | 0.328 |
| MOD_GSK3_1 | 277 | 284 | PF00069 | 0.243 |
| MOD_GSK3_1 | 309 | 316 | PF00069 | 0.466 |
| MOD_N-GLC_1 | 274 | 279 | PF02516 | 0.567 |
| MOD_N-GLC_1 | 313 | 318 | PF02516 | 0.614 |
| MOD_NEK2_1 | 17 | 22 | PF00069 | 0.427 |
| MOD_NEK2_1 | 219 | 224 | PF00069 | 0.260 |
| MOD_NEK2_1 | 274 | 279 | PF00069 | 0.349 |
| MOD_NEK2_1 | 295 | 300 | PF00069 | 0.289 |
| MOD_NEK2_1 | 44 | 49 | PF00069 | 0.460 |
| MOD_NEK2_1 | 95 | 100 | PF00069 | 0.288 |
| MOD_NEK2_2 | 182 | 187 | PF00069 | 0.251 |
| MOD_PIKK_1 | 110 | 116 | PF00454 | 0.307 |
| MOD_PK_1 | 147 | 153 | PF00069 | 0.339 |
| MOD_PKA_2 | 5 | 11 | PF00069 | 0.479 |
| MOD_PKA_2 | 68 | 74 | PF00069 | 0.270 |
| MOD_Plk_4 | 147 | 153 | PF00069 | 0.314 |
| MOD_Plk_4 | 182 | 188 | PF00069 | 0.289 |
| MOD_Plk_4 | 200 | 206 | PF00069 | 0.169 |
| MOD_Plk_4 | 261 | 267 | PF00069 | 0.304 |
| MOD_Plk_4 | 269 | 275 | PF00069 | 0.305 |
| MOD_Plk_4 | 290 | 296 | PF00069 | 0.347 |
| MOD_Plk_4 | 73 | 79 | PF00069 | 0.273 |
| MOD_Plk_4 | 8 | 14 | PF00069 | 0.412 |
| MOD_ProDKin_1 | 157 | 163 | PF00069 | 0.273 |
| MOD_SUMO_rev_2 | 168 | 172 | PF00179 | 0.279 |
| TRG_DiLeu_BaEn_1 | 269 | 274 | PF01217 | 0.291 |
| TRG_DiLeu_BaLyEn_6 | 162 | 167 | PF01217 | 0.339 |
| TRG_ENDOCYTIC_2 | 213 | 216 | PF00928 | 0.273 |
| TRG_ENDOCYTIC_2 | 271 | 274 | PF00928 | 0.315 |
| TRG_ENDOCYTIC_2 | 29 | 32 | PF00928 | 0.400 |
| TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.339 |
| TRG_ER_diArg_1 | 145 | 147 | PF00400 | 0.271 |
| TRG_ER_diArg_1 | 164 | 166 | PF00400 | 0.174 |
| TRG_ER_diArg_1 | 211 | 213 | PF00400 | 0.273 |
| TRG_ER_diArg_1 | 285 | 287 | PF00400 | 0.425 |
| TRG_NES_CRM1_1 | 256 | 269 | PF08389 | 0.303 |
| TRG_Pf-PMV_PEXEL_1 | 164 | 169 | PF00026 | 0.459 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1IJ31 | Leptomonas seymouri | 81% | 98% |
| A0A1X0P6S3 | Trypanosomatidae | 54% | 100% |
| A0A3S5H727 | Leishmania donovani | 99% | 100% |
| A4H9E0 | Leishmania braziliensis | 82% | 100% |
| B6DTF5 | Bodo saltans | 39% | 100% |
| D0A043 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 100% |
| E9ARH3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
| O24326 | Phaseolus vulgaris | 23% | 72% |
| O89017 | Mus musculus | 27% | 82% |
| P49048 | Caenorhabditis elegans | 37% | 100% |
| Q4QE06 | Leishmania major | 91% | 100% |
| Q4R4T8 | Macaca fascicularis | 26% | 82% |
| Q5R5D9 | Pongo abelii | 27% | 82% |
| Q8T4E1 | Drosophila melanogaster | 35% | 100% |
| Q92643 | Homo sapiens | 39% | 90% |
| Q95M12 | Bos taurus | 27% | 82% |
| Q99538 | Homo sapiens | 27% | 82% |
| Q9USP5 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 37% | 94% |
| V5BWA3 | Trypanosoma cruzi | 54% | 100% |